Cargando…
GINS4 might be a novel prognostic immune-related biomarker of not only esophageal squamous cell carcinoma and other cancers
BACKGROUND: Immunotherapy using immune checkpoint inhibitors (ICIs), such as antibody of programmed death-1 (PD-1)/programmed death-ligand 1 (PD-L1) has showed as a promising treatment for esophageal squamous cell carcinoma (ESCC), but resistance is unavoidable. This study aimed to find more immune-...
Autores principales: | Jin, Donghui, Yuan, Ligong, Li, Feng, Wang, Shuaibo, Mao, Yousheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976371/ https://www.ncbi.nlm.nih.gov/pubmed/35365175 http://dx.doi.org/10.1186/s12920-022-01223-x |
Ejemplares similares
-
Identification of Tumor Microenvironment-Related Prognostic lncRNAs in Lung Adenocarcinoma
por: Yuan, Ligong, et al.
Publicado: (2021) -
Effect of histology on the efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer: A systematic review and meta-analysis
por: Li, Feng, et al.
Publicado: (2022) -
A novel prognostic biomarker: GINS3 is correlated with methylation and immune escape in liver hepatocellular carcinoma
por: Lai, Tianqi, et al.
Publicado: (2023) -
Mesenchymal cystic hamartoma of the lung: A case report
por: Yuan, Ligong, et al.
Publicado: (2022) -
Identification of GINS2 prognostic potential and involvement in immune cell infiltration in hepatocellular carcinoma
por: Li, Zuyin, et al.
Publicado: (2022)